These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 15774248)

  • 1. Low incidence of acute urinary retention in the general male population: the triumph project.
    Verhamme KM; Dieleman JP; van Wijk MA; Bosch JL; Stricker BH; Sturkenboom MC
    Eur Urol; 2005 Apr; 47(4):494-8. PubMed ID: 15774248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The natural history of benign prostatic hyperplasia.
    Fitzpatrick JM
    BJU Int; 2006 Apr; 97 Suppl 2():3-6; discussion 21-2. PubMed ID: 16507045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alfuzosin 10 mg once daily prevents overall clinical progression of benign prostatic hyperplasia but not acute urinary retention: results of a 2-year placebo-controlled study.
    Roehrborn CG
    BJU Int; 2006 Apr; 97(4):734-41. PubMed ID: 16536764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Symptom deterioration during treatment and history of AUR are the strongest predictors for AUR and BPH-related surgery in men with LUTS treated with alfuzosin 10 mg once daily.
    Emberton M; Elhilali M; Matzkin H; Harving N; van Moorselaar J; Hartung R; Alcaraz A; Vallancien G;
    Urology; 2005 Aug; 66(2):316-22. PubMed ID: 16098361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonsteroidal anti-inflammatory drugs and increased risk of acute urinary retention.
    Verhamme KM; Dieleman JP; Van Wijk MA; van der Lei J; Bosch JL; Stricker BH; Sturkenboom MC
    Arch Intern Med; 2005 Jul; 165(13):1547-51. PubMed ID: 16009872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhaled anticholinergic drugs and risk of acute urinary retention.
    Afonso AS; Verhamme KM; Stricker BH; Sturkenboom MC; Brusselle GG
    BJU Int; 2011 Apr; 107(8):1265-72. PubMed ID: 20880196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A large retrospective analysis of acute urinary retention and prostate-related surgery in BPH patients treated with 5-alpha reductase inhibitors: dutasteride versus finasteride.
    Issa MM; Runken MC; Grogg AL; Shah MB
    Am J Manag Care; 2007 Feb; 13 Suppl 1():S10-6. PubMed ID: 17295600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Asian multinational prospective observational registry of patients with benign prostatic hyperplasia, with a focus on comorbidities, lower urinary tract symptoms and sexual function.
    Li MK; Garcia L; Patron N; Moh LC; Sundram M; Leungwattanakij S; Pripatnanont C; Cheng C; Chi-Wai M; Loi-Cheong N
    BJU Int; 2008 Jan; 101(2):197-202. PubMed ID: 18005205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The management of acute urinary retention in France: a cross-sectional survey in 2618 men with benign prostatic hyperplasia.
    Desgrandchamps F; De La Taille A; Doublet JD;
    BJU Int; 2006 Apr; 97(4):727-33. PubMed ID: 16536763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of delaying 5-alpha reductase inhibitor therapy in men on alpha-blocker therapy to treat BPH: assessment of acute urinary retention and prostate-related surgery.
    Naslund M; Eaddy MT; Hogue SL; Kruep EJ; Shah MB
    Curr Med Res Opin; 2009 Nov; 25(11):2663-9. PubMed ID: 19757985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Definition of at-risk patients: dynamic variables.
    Emberton M
    BJU Int; 2006 Apr; 97 Suppl 2():12-5; discussion 21-2. PubMed ID: 16507047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-Alpha reductase inhibition provides superior benefits to alpha blockade by preventing AUR and BPH-related surgery.
    Boyle P; Roehrborn C; Harkaway R; Logie J; de la Rosette J; Emberton M
    Eur Urol; 2004 May; 45(5):620-6; discussion 626-7. PubMed ID: 15082205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alfuzosin 10 mg once daily for treating benign prostatic hyperplasia: a 3-year experience in real-life practice.
    Vallancien G; Emberton M; Alcaraz A; Matzkin H; van Moorselaar RJ; Hartung R; Harving N; Elhilali M;
    BJU Int; 2008 Apr; 101(7):847-52. PubMed ID: 18321317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BPH progression: concept and key learning from MTOPS, ALTESS, COMBAT, and ALF-ONE.
    Roehrborn CG
    BJU Int; 2008 Mar; 101 Suppl 3():17-21. PubMed ID: 18307681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence and prevalence of lower urinary tract symptoms suggestive of benign prostatic hyperplasia in primary care--the Triumph project.
    Verhamme KM; Dieleman JP; Bleumink GS; van der Lei J; Sturkenboom MC; Artibani W; Begaud B; Berges R; Borkowski A; Chappel CR; Costello A; Dobronski P; Farmer RD; Jiménez Cruz F; Jonas U; MacRae K; Pientka L; Rutten FF; van Schayck CP; Speakman MJ; Sturkenboom MC; Tiellac P; Tubaro A; Vallencien G; Vela Navarrete R;
    Eur Urol; 2002 Oct; 42(4):323-8. PubMed ID: 12361895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute urinary retention increases the risk of complications after transurethral resection of the prostate: a population-based study.
    Chen JS; Chang CH; Yang WH; Kao YH
    BJU Int; 2012 Dec; 110(11 Pt C):E896-901. PubMed ID: 23035623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Definition of at-risk patients: baseline variables.
    Roehrborn CG
    BJU Int; 2006 Apr; 97 Suppl 2():7-11; discussion 21-2. PubMed ID: 16507046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sustained decrease in incidence of acute urinary retention and surgery with finasteride for 6 years in men with benign prostatic hyperplasia.
    Roehrborn CG; Bruskewitz R; Nickel JC; McConnell JD; Saltzman B; Gittelman MC; Malek GH; Gottesman JE; Suryawanshi S; Drisko J; Meehan A; Waldstreicher J;
    J Urol; 2004 Mar; 171(3):1194-8. PubMed ID: 14767299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does open radical retropubic prostatectomy decrease the risk of acute urinary retention?
    Tareen B; Godoy G; Laze J; Lepor H
    Urology; 2008 Oct; 72(4):821-4. PubMed ID: 18602148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The incidence of acute urinary retention secondary to BPH is increasing among California men.
    Groves HK; Chang D; Palazzi K; Cohen S; Parsons JK
    Prostate Cancer Prostatic Dis; 2013 Sep; 16(3):260-5. PubMed ID: 23648398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.